Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Status:
Completed
Trial end date:
2019-04-22
Target enrollment:
Participant gender:
Summary
Phase 3 study to evaluate the safety and efficacy of treatment with RVL-1201 compared to
placebo for treatment of blepharoptosis. Eligible subjects will be randomized to one of 2
treatment arms.